material_safety_data_sheet_letter_new_.doc ALLERGAN 2525 Dupont Drive, P.OCUFLOX ® (Ofloxacin Ophthalmic Solution) 0.3% SANCTURA® (trospium chloride), 20 mg tablets Ofloxacin SANCTURA XR® (trospium chloride), 60 mg tablets OPHTHETIC® (Proparacaine HCl Ophthalmic Solution) 0.5% Trimethoprim Sulfate and Polymyxin B Sulfate,...
author: hutton_ronald
material_safety_data_sheet_letter_new_.doc page 2
author: hutton_ronald
Prostatitis: Prostate Disorders: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Problems at the Destination: Travel and Health: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Leprosy: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Gonorrhea: Sexually Transmitted Diseases: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
http://www.fda.gov/cder/orange/appendix_a.txt IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, BACITRACIN ZINC NEOSPORIN, GRAMICIDIN NEOSPORIN, NEOMYCIN SULFATE (OTC) NEOTHYLLINE, DYPHYLLINE NEOTRIZINE, TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE; SULFAMETHAZINE) NEPHRAMINE 5.4%, AMINO ACIDS NEPHROFLOW, IODOHIPPURATE SODIUM, I-123 NEPTAZANE, METHAZOLAMIDE NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE...
Summaries of Medical and Clinical Pharmacology Reviews of Pediatric Studies Food and Drug Administration • Center for Drug Evaluation and Research Pediatrics Search Summaries of Medical and Clinical Pharmacology Reviews of Pediatric Studies as of January 28, 2004 Summaries of Medical and Clinical Pharmacology Reviews Drug Sponsor Review Summary Alendronate - Fosamax Merck Medical Clinical Pharmacology Atovaquone and Proguanil - Malarone- GlaxoSmithKline...
author: CDER Office of New Drugs
1997 Warning Letters and Notice of Violation Letters to Pharmaceutical Companies In the News: - FDA Takes Action Against Firm Marketing Unapproved Drugs - [ 2004 ] [ 2003 ] [ 2002 ] [ 2001 ] [ 2000 ] [ 1999 ][ 1998 ] - 1997 January Product Company Division Released Caverject (alprostadil) for injection Pharmacia and Upjohn Company DDMAC 1/27/97 Decapeptyl (Triptorelin Pamoate) Ferring Pharmaceuticals DDMAC 1/15/97 Edex (Alprostadil) for Injection Schwarz Pharma...
Pharmaceutical Research and Manufacturers of America - Allergan Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes Botox¨ Botox¨ / botulinum toxin type A Cerebral Palsy Cervical Dystonia Allergan Irvine, CA Phase III 2 years - 7 years - cyclosporine...
Pharmaceutical Research and Manufacturers of America - treatment of bacterial conjunctivitis Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes Ocuflox none / ofloxacin 0.3% treatment of bacterial conjunctivitis Allergan Irvine, CA application...
Microsoft Word - Medication_Listing.doc page 23
author: Wendy Daws
Microsoft Word - Master_Index.doc S.®) 14 28: 08.08 morphine sulfate sustained release (MS Contin®, M- Eslon®) Autosubstitution to Lowest Cost Alternative morphine SR product (ASL- 14 28: 08.08 morphine sulphate 14 28: 08.08 Motilium® 28 56: 40 Motrin® 16 28: 08.04 MS Contin® Autosubstitution to Lowest Cost Alternative morphine SR product (ASL- 01) 14 28: 08.08 multivitamin 36 88: 28...
author: Wendy Daws
Microsoft Word - Master_Index.doc page 38
author: Wendy Daws
4:00 page 32
author: Christine Wildman
4:00 page 23
author: Christine Wildman
02-104 NewMed Children 5/13 AstraZeneca management of acute pulmonary Phase III meropenem for Wilmington, DE exacerbations in cystic fibrosis 5 years and older injection patients due to respiratory tract (800) 456- 3669 (Orphan Drug) infections with susceptible organisms MOLI 1901 Molichem Medicines cystic fibrosis Phase I/ II (Orphan Drug) Chapel Hill, NC (919) 960- 0217 PA 1806 Chiron cystic fibrosis Phase II...
author: RL
02-104 NewMed Children 5/13 page 9
author: RL
FDA Drug Approvals List November 1999 Approvable Original New Drug Applications Original Application #: 020125 Approvable Date: 30-NOV-99 Trade Name: ACCURETIC Dosage Form: TABLET Applicant: PARKE DAVIS PHARMACEUTICAL RESEARCH DIV WARNER LAMBERT CO Active Ingredient(s): QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE OTC/RX Status: RX Original Abbreviated Application #: 075366 Tentative Approval Date: 02-NOV-99 Trade Name:...
DDPA May 1996 Drug and Device Product Approvals for May 1996 ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 16-191 SORBITRATE ZENECA ISOSORBIDE DINITRATE 01-APR-96 (TABLET, SUBLINGUAL) WILMINGTON, DE 2.5MG (SUPPL-033) 19850 5MG (VASODILATOR) [MET CONDITIONS FOR APPROVAL PER FEDERAL REGISTER NOTICE OF AUGUST 3, 1984 (49 FR 31151)] 16-192 SORBITRATE ZENECA ISOSORBIDE DINITRATE 01-APR-96 ...
PowerPoint Presentation 2005 Annual Meeting of Shareholders March 17, 2005 Gerald J.
author: Amy Vavrunek
PowerPoint Presentation page 27
author: Amy Vavrunek
http://www.fda.gov/cder/biologics/review/omalgen062003r1.pdf page 70
C:\Sonny files\Team 2 Files\Ophthalmics\CiproHC Otic\11015 071803 V\ IOL CiproHCOtic.doc page 5
author: Sonny Saini
1014639.PDF UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.
author: norkinr
